Next Article in Journal / Special Issue
RT-PCR Testing of Organ Culture Medium for Corneal Storage Fails to Detect SARS-CoV-2 Infection Due to Lack of Viral Replication
Previous Article in Journal
First Isolation of Virulent Tenacibaculum maritimum Isolates from Diseased Orbicular Batfish (Platax orbicularis) Farmed in Tahiti Island
Previous Article in Special Issue
Local Emergence of a del HV69-70 SARS-CoV-2 Variant in Burgundy, France
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives

1
Population Registry of Cali, Department of Pathology, Universidad del Valle, Cali 760042, Colombia
2
Laboratorio de Oncovirología, Programa de Virología, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago 8380000, Chile
3
Advanced Center for Chronic Diseases (ACCDiS), Pontificia Universidad Católica de Chile, Santiago 8320000, Chile
4
Instituto de Alta Investigación, Universidad de Tarapacá, Arica 1000000, Chile
5
Center for Radiological Research, Columbia University Medical Center, New York, NY 10032, USA
6
Universidad de Tarapacá, Arica 1000000, Chile
*
Author to whom correspondence should be addressed.
Pathogens 2022, 11(2), 132; https://doi.org/10.3390/pathogens11020132
Submission received: 15 December 2021 / Revised: 17 January 2022 / Accepted: 17 January 2022 / Published: 21 January 2022
(This article belongs to the Collection Feature Papers in Viral Pathogens)

Abstract

Lung cancer (LC) is the leading cause of cancer death worldwide. Tobacco smoke is the most frequent risk factor etiologically associated with LC, although exposures to other environmental factors such as arsenic, radon or asbestos are also involved. Additionally, the involvement of some viral infections such as high-risk human papillomaviruses (HR-HPVs), Merkel cell polyomavirus (MCPyV), Jaagsiekte Sheep Retrovirus (JSRV), John Cunningham Virus (JCV), and Epstein–Barr virus (EBV) has been suggested in LC, though an etiological relationship has not yet been established. EBV is a ubiquitous gamma herpesvirus causing persistent infections and some lymphoid and epithelial tumors. Since EBV is heterogeneously detected in LCs from different parts of the world, in this review we address the epidemiological and experimental evidence of a potential role of EBV. Considering this evidence, we propose mechanisms potentially involved in EBV-associated lung carcinogenesis. Additional studies are warranted to dissect the role of EBV in this very frequent malignancy.
Keywords: Epstein–Barr virus; cancer; lung Epstein–Barr virus; cancer; lung

Share and Cite

MDPI and ACS Style

Osorio, J.C.; Blanco, R.; Corvalán, A.H.; Muñoz, J.P.; Calaf, G.M.; Aguayo, F. Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives. Pathogens 2022, 11, 132. https://doi.org/10.3390/pathogens11020132

AMA Style

Osorio JC, Blanco R, Corvalán AH, Muñoz JP, Calaf GM, Aguayo F. Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives. Pathogens. 2022; 11(2):132. https://doi.org/10.3390/pathogens11020132

Chicago/Turabian Style

Osorio, Julio C., Rancés Blanco, Alejandro H. Corvalán, Juan P. Muñoz, Gloria M. Calaf, and Francisco Aguayo. 2022. "Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives" Pathogens 11, no. 2: 132. https://doi.org/10.3390/pathogens11020132

APA Style

Osorio, J. C., Blanco, R., Corvalán, A. H., Muñoz, J. P., Calaf, G. M., & Aguayo, F. (2022). Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives. Pathogens, 11(2), 132. https://doi.org/10.3390/pathogens11020132

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop